You have 9 free searches left this month | for more free features.

ferumoxytol

Showing 1 - 25 of 49

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Multiple Sclerosis Trial run by the National Institute of Neurological Disorders and Stroke (NINDS) (Ferumoxytol)

Completed
  • Multiple Sclerosis
  • Ferumoxytol
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 25, 2023

Anemia Trial in Baltimore (ferumoxytol, moxifloxacin, )

Completed
  • Anemia
  • ferumoxytol
  • +2 more
  • Baltimore, Maryland
    (unnamed)
Apr 1, 2022

CNS Tumor, Cranial Nerve Disorder, Metastatic Malignant Tumor in the Brain Trial in Portland (Ferumoxytol, Gadolinium, Magnetic

Recruiting
  • Central Nervous System Neoplasm
  • +2 more
  • Ferumoxytol
  • +2 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jun 2, 2022

Iron Deficiency Anemia of Pregnancy Trial in Tucson (Ferrous sulfate 325mg, Ferumoxytol)

Completed
  • Iron Deficiency Anemia of Pregnancy
  • Ferrous sulfate 325mg
  • Ferumoxytol
  • Tucson, Arizona
    University of Arizona
Sep 5, 2022

Iron Deficiency Anemia Trial in Waltham (Ferumoxytol)

Terminated
  • Iron Deficiency Anemia
  • Ferumoxytol
  • Waltham, Massachusetts
    AMAG Pharmaceuticals, Inc.
Mar 31, 2022

Lung Carcinoma Metastatic in the Brain, Stage IV Lung Non-Small Cell Cancer AJCC v7 Trial in Portland (drug, other, procedure,

Terminated
  • Lung Carcinoma Metastatic in the Brain
  • Stage IV Lung Non-Small Cell Cancer AJCC v7
  • Ferumoxytol
  • +3 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jul 14, 2022

Iron Deficiency Anemia Trial in Waltham (Ferumoxytol, Oral Iron)

Terminated
  • Iron Deficiency Anemia
  • Ferumoxytol
  • Oral Iron
  • Waltham, Massachusetts
    AMAG Pharmaceuticals, Inc.
Mar 31, 2022

Brain Tumor Trial (Ferumoxytol, Magnetic Resonance Imaging)

Withdrawn
  • Brain Neoplasm
  • Ferumoxytol
  • Magnetic Resonance Imaging
  • (no location specified)
Nov 3, 2021

Locally Advanced Rectal Carcinoma, Stage III Rectal Cancer AJCC v7, Stage IIIA Rectal Cancer AJCC v7 Trial in Portland

Terminated
  • Locally Advanced Rectal Carcinoma
  • +4 more
  • Contrast-enhanced Magnetic Resonance Imaging
  • Ferumoxytol
  • Portland, Oregon
    OHSU Knight Cancer Institute
Sep 2, 2021

Stage IIB Esophageal Cancer AJCC v7, Stage III Esophageal Cancer AJCC v7, Stage IIIA Esophageal Cancer AJCC v7 Trial

Withdrawn
  • Stage IIB Esophageal Cancer AJCC v7
  • +4 more
  • Ferumoxytol
  • Magnetic Resonance Imaging
  • (no location specified)
Sep 8, 2021

Glioblastoma Trial in Columbus, Portland (Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging, Ferumoxytol,

Completed
  • Glioblastoma
  • Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging
  • +3 more
  • Columbus, Ohio
  • +1 more
Mar 11, 2022

Metastatic Malignant Tumor in the Brain, Primary Brain Tumor Trial in Portland (3 Tesla Magnetic Resonance Imaging, Dynamic

Terminated
  • Metastatic Malignant Neoplasm in the Brain
  • Primary Brain Neoplasm
  • 3 Tesla Magnetic Resonance Imaging
  • +6 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Nov 3, 2021

Head Neck Cancer Trial in Houston (Magnetic Resonance Imaging (MRI), Ferumoxytol)

Terminated
  • Head and Neck Cancer
  • Magnetic Resonance Imaging (MRI)
  • Ferumoxytol
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 15, 2021

Hereditary Pancreatic Carcinoma, Pancreatic Adenocarcinoma, Pancreatic Intraductal Papillary-Mucinous Tumor Trial in Portland

Recruiting
  • Hereditary Pancreatic Carcinoma
  • +2 more
  • Dynamic Contrast-Enhanced Magnetic Resonance Imaging
  • Ferumoxytol
  • Portland, Oregon
    OHSU Knight Cancer Institute
Aug 16, 2022

IC - Interstitial Cystitis Trial in Pittsburgh (Ferumoxytol, Gadobutrol)

Recruiting
  • IC - Interstitial Cystitis
  • Pittsburgh, Pennsylvania
    UPMC Magee Women's Hospital
Apr 10, 2023

Pediatric Congenital Heart Disease Trial in Los Angeles (ferumoxytol, gadofosveset)

Completed
  • Pediatric Congenital Heart Disease
  • Los Angeles, California
    UCLA Medical Center
Nov 22, 2022

Malignant Solid Tumor Trial in United States (drug, other, procedure)

Active, not recruiting
  • Malignant Solid Neoplasm
  • Ferumoxytol
  • +4 more
  • Baltimore, Maryland
  • +5 more
Nov 8, 2022

Soft Tissue Sarcoma Trial in Boston (Ferumoxytol)

Withdrawn
  • Soft Tissue Sarcoma
  • Ferumoxytol
  • Boston, Massachusetts
  • +3 more
Oct 14, 2020

Anemia, Iron Deficiency, Heavy Menstrual Bleeding Trial in Philadelphia (Ferumoxytol, Ferrous Sulfate)

Recruiting
  • Anemia, Iron Deficiency
  • Heavy Menstrual Bleeding
  • Ferumoxytol
  • Ferrous Sulfate
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Oct 13, 2021

Iron Deficiency Anemia Trial in Baltimore (Ferumoxytol, Saline, Ferrous sulfate tablets)

Recruiting
  • Iron Deficiency Anemia
  • Ferumoxytol
  • +3 more
  • Baltimore, Maryland
    Auerbach Hematology and Oncology
Feb 16, 2022

Pregnancy Related, Anemia, Iron Deficiency, Anemia of Pregnancy Trial in Philadelphia (Ferumoxytol, Ferrous Sulfate)

Recruiting
  • Pregnancy Related
  • +2 more
  • Ferumoxytol
  • Ferrous Sulfate
  • Philadelphia, Pennsylvania
    Thomas Jefferson University Hospital
Feb 4, 2022

Cancer Trial in Stanford (WB-DW-MR scan, 18-F-FDG PET scan, Ferumoxytol)

Recruiting
  • Cancer
  • WB-DW-MR scan
  • +3 more
  • Stanford, California
    Stanford University Cancer Institute
Sep 1, 2021

Iron Deficiency Anemia Trial in Worldwide (Ferumoxytol)

Completed
  • Iron Deficiency Anemia
  • Ferumoxytol
  • Birmingham, Alabama
  • +139 more
Mar 31, 2022

Prostate Cancer, Bladder Cancer, Kidney Cancer Trial run by the NCI (Ferumoxytol, Magnetic Resonance Imaging (MRI))

Completed
  • Prostate Cancer
  • +2 more
  • Ferumoxytol
  • Magnetic Resonance Imaging (MRI)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 5, 2019

Nervous System Diseases, Diagnostic Imaging Trial in Portland (Ferumoxytol)

Unknown status
  • Nervous System Diseases
  • Diagnostic Imaging
  • Ferumoxytol
  • Portland, Oregon
    Oregon Health & Science University
Jul 22, 2019